Applications of chitin and its derivatives in biological medicine

International Journal of Molecular Sciences

Volumn 11, Issue 12, 2010, Pages 5152-5164

  Park, Bae Keun ^a   Kim, Moon Moo ^b  

^a Yonsei University Wonju College of Medicine   (South Korea)

^b Dong Eui University   (South Korea)

Author keywords

Anti inflammatory; Anticancer; Antioxidant; Chitin; Chitosan; Drug delivery

Indexed keywords

BAICALIN; CARBOXYLATED CHITOOLIGOSACCHARIDE DERIVATIVE; CHITIN DERIVATIVE; CHITOOLIGOSACCHARIDE DERIVATIVE; CHITOSAN DERIVATIVE; GAMMA INTERFERON; GELATINASE A; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 6; NANOPARTICLE; NONSTEROID ANTIINFLAMMATORY AGENT; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BIOMATERIAL; CHITOSAN; OLIGOSACCHARIDE;

ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BIOCOMPATIBILITY; BIOLOGICAL ACTIVITY; CANCER INHIBITION; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG HYDROLYSIS; DRUG INDICATION; DRUG PENETRATION; DRUG STABILITY; DRUG STRUCTURE; HUMAN; IMMUNOSTIMULATION; INFLAMMATION; KIDNEY DISEASE; LIPID PEROXIDATION; LIVER DISEASE; LUNG CARCINOMA; LUNG METASTASIS; LYMPHOCYTE PROLIFERATION; MACROPHAGE ACTIVATION; NONHUMAN; OXIDATIVE STRESS; REVIEW; SKIN DISEASE; STOMACH DISEASE; T LYMPHOCYTE ACTIVATION; ANIMAL; CHEMISTRY; HYDROLYSIS;

ANIMALS; BIOCOMPATIBLE MATERIALS; CHITOSAN; HUMANS; HYDROLYSIS; OLIGOSACCHARIDES;

EID: 78650988466     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms11125152     Document Type: Review

References (98)

1. Domard, A.; Domard, M. Chitosan: Structureproperties relationship and biomedical applications. Polym. Biomater. 2002, 9, 187-212.
2. Lavall, R.; Assis, O.; Campana-Filho, S. [beta]-Chitin from the pens of Loligo sp.: Extraction and characterization. Bioresour. Technol. 2007, 98, 2465-2472.
3. Ngo, D.; Kim, M.; Kim, S. Chitin oligosaccharides inhibit oxidative stress in live cells. Carbohydr. Polym. 2008, 74, 228-234.
4. Abdou, E.; Nagy, K.; Elsabee, M. Extraction and characterization of chitin and chitosan from local sources. Bioresour. Technol. 2008, 99, 1359-1367.
5. Lee, D.; Xia, W.; Zhang, J. Enzymatic preparation of chitooligosaccharides by commercial lipase. Food Chem. 2008, 111, 291-295.
6. Lin, S.; Lin, Y.; Chen, H. Low molecular weight chitosan prepared with the aid of cellulase, lysozyme and chitinase: Characterisation and antibacterial activity. Food Chem. 2009, 116, 47-53.
7. Agnihotri, S.; Mallikarjuna, N.; Aminabhavi, T. Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J. Controll. Release 2004, 100, 5-28.
8. Kumar, M.; Muzzarelli, R.; Muzzarelli, C.; Sashiwa, H.; Domb, A. Chitosan chemistry and pharmaceutical perspectives. Chem. Rev. 2004, 104, 6017-6084
9. Xia, W.; Liu, P.; Zhang, J.; Chen, J. Biological activities of chitosan and chitooligosaccharides. Food Hydrocoll. 2011, 25, 170-179.
10. Knorr, D. Use of chitinous polymers in food: A challenge for food research and development. Food Technol. (USA) 1984, 38, 85-89.
11. Kurita, K. Chemistry and application of chitin and chitosan. Polym. Degrad. Stabil. 1998, 59, 117-120.
12. Razdan, A.; Pettersson, D. Effect of chitin and chitosan on nutrient digestibility and plasma lipid concentrations in broiler chickens. Brit. J. Nutr. 1994, 72, 277-288.
13. Ngo, D.; Lee, S.; Kim, M.; Kim, S. Production of chitin oligosaccharides with different molecular weights and their antioxidant effect in RAW 264.7 cells. J. Funct. Foods 2009, 1, 188-198.
14. Ribeiro, M.; Espiga, A.; Silva, D.; Baptista, P.; Henriques, J.; Ferreira, C.; Silva, J.; Borges, J.; Pires, E.; Chaves, P. Development of a new chitosan hydrogel for wound dressing. Wound Repair Regen. 2009, 17, 817-824.
15. Lim, C.; Yaacob, N.; Ismail, Z.; Halim, A. In vitro biocompatibility of chitosan porous skin regenerating templates (PSRTs) using primary human skin keratinocytes. Toxicol. in Vitro 2010, 24, 721-727.
16. Li, Z.; Yubao, L.; Yi, Z.; Lan, W.; Jansen, J. In vitro and in vivo evaluation on the bioactivity of ZnO containing nano-hydroxyapatite/chitosan cement. J. Biomed. Mater. Res. A 2010, 93, 269-279.
17. Kulikov, S.; Chirkov, S.; Il-ina, A.; Lopatin, S.; Varlamov, V. Effect of the molecular weight of chitosan on its antiviral activity in plants. Appl. Biochem. Microbiol. 2006, 42, 200-203.
18. Wang, S.; Chen, J. The protective effect of chitin and chitosan against Vibrio alginolyticus in white shrimp Litopenaeus vannamei. Fish Shellfish Immunol. 2005, 19, 191-204.
19. Rajesh Kumar, S.; Ishaq Ahmed, V.; Parameswaran, V.; Sudhakaran, R.; Sarath Babu, V.; Sahul Hameed, A. Potential use of chitosan nanoparticles for oral delivery of DNA vaccine in Asian sea bass (Lates calcarifer) to protect from Vibrio (Listonella) anguillarum. Fish Shellfish Immunol. 2008, 25, 47-56.
20. Arnaud, T.; Neto, B.; Diniz, F. Chitosan effect on dental enamel de-remineralization: An in vitro evaluation. J. Dentistry 2010, 38, 848-852.
21. Khor, E.; Lim, L. Implantable applications of chitin and chitosan. Biomaterials 2003, 24, 2339-2349.
22. Mark, H.; Bikales, N.; Overberger, C.; Menges, G. Encyclopedia of Polymer Science and Engineering; Wiley-Interscience: New York, NY, USA, 1986.
23. Morganti, P.; Morganti, G. Chitin nanofibrils for advanced cosmeceuticals. Clin. Dermatol. 2008, 26, 334-340.
24. Peniche Covas, C.; Alvarez, L.; Arguelles Monal, W. The adsorption of mercuric ions by chitosan. J. Appl. Polym. Sci. 1992, 46, 1147-1150.
25. Mckay, G.; Blair, H.; Gardner, J. Adsorption of dyes on chitin. I. Equilibrium studies. J. Appl. Polym. Sci. 1982, 27, 3043-3057.
26. Chatelet, C.; Damour, O.; Domard, A. Influence of the degree of acetylation on some biological properties of chitosan films. Biomaterials 2001, 22, 261-268.
27. Kim, C.; Choi, Y.; Lee, S.; Gin, Y.; Son, Y. Development of chitosan dermal scaffold and its characterization. Key Eng. Mater. 2007, 342, 181-184.
28. Rahman, I.; Biswas, S.; Kode, A. Oxidant and antioxidant balance in the airways and airway diseases. Eur. J. Pharmacol. 2006, 533, 222-239.
29. Blagosklonny, M. Aging: ROS or TOR. Cell Cycle 2008, 7, 3344-3354.
30. Maynard, S.; Schurman, S.; Harboe, C.; de Souza-Pinto, N.; Bohr, V. Base excision repair of oxidative DNA damage and association with cancer and aging. Carcinogenesis 2009, 30, 2-10.
31. Mirshafiey, A.; Mohsenzadegan, M. The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis. Iran J. Allergy Asthma Immunol.2008, 7, 195-202.
32. Pillai, S.; Oresajo, C.; Hayward, J. Ultraviolet radiation and skin aging: Roles of reactive oxygen species, inflammation and protease activation, and strategies for prevention of inflammation- induced matrix degradation-a review. Int. J. Cosmet. Sci. 2005, 27, 17-34.
33. Leung, P.; Chan, Y. Role of oxidative stress in pancreatic inflammation. Antioxid. Redox Signal. 2009, 11, 135-166.
34. Jeon, Y.; Kim, S. Continuous production of chitooligosaccharides using a dual reactor system. Process Biochem. 2000, 35, 623-632.
35. Chen, A.; Taguchi, T.; Sakai, K.; Kikuchi, K.; Wang, M.; Miwa, I. Antioxidant activities of chitobiose and chitotriose. Biol. Pharm. Bull. 2003, 26, 1326-1330.
36. Zeng, K.; Deng, Y.; Ming, J.; Deng, L. Induction of disease resistance and ROS metabolism in navel oranges by chitosan. Sci. Horticulturae 2010, 128, 223-228.
37. Mendis, E.; Kim, M.; Rajapakse, N.; Kim, S. An in vitro cellular analysis of the radical scavenging efficacy of chitooligosaccharides. Life Sci. 2007, 80, 2118-2127.
38. Mori, T.; Murakami, M.; Okumura, M.; Kadosawa, T.; Uede, T.; Fujinaga, T. Mechanism of macrophage activation by chitin derivatives. J. Vet. Med. Sci. 2005, 67, 51-56.
39. Liu, H.; Li, W.; Xu, G.; Li, X.; Bai, X.; Wei, P.; Yu, C.; Du, Y. Chitosan oligosaccharides attenuate hydrogen peroxide-induced stress injury in human umbilical vein endothelial cells. Pharmacol. Res. 2009, 59, 167-175.
40. Xu, W.; Huang, H.; Lin, C.; Jiang, Z. Chitooligosaccharides protect rat cortical neurons against copper induced damage by attenuating intracellular level of reactive oxygen species. Bioorg. Med. Chem. Lett. 2010, 20, 3084-3088.
41. Karadeniz, F.; Artan, M.; Kong, C.; Kim, S. Chitooligosaccharides protect pancreatic [beta]-cells from hydrogen peroxide-induced deterioration. Carbohydr. Polym. 2010, 82, 143-147
42. Xu, Q.; Ma, P.; Yu, W.; Tan, C.; Liu, H.; Xiong, C.; Qiao, Y.; Du, Y. Chitooligosaccharides Protect Human Embryonic Hepatocytes Against Oxidative Stress Induced by Hydrogen Peroxide. Mar. Biotechnol. 2010, 12, 292-298.
43. Anraku, M.; Kabashima, M.; Namura, H.; Maruyama, T.; Otagiri, M.; Gebicki, J.; Furutani, N.; Tomida, H. Antioxidant protection of human serum albumin by chitosan. Int. J. Biol. Macromol. 2008, 43, 159-164.
44. Rajapakse, N.; Kim, M.; Mendis, E.; Kim, S. Inhibition of free radical-mediated oxidation of cellular biomolecules by carboxylated chitooligosaccharides. Bioorg. Med. Chem. 2007, 15, 997-1003.
45. Drayton, D.; Liao, S.; Mounzer, R.; Ruddle, N. Lymphoid organ development: From ontogeny to neogenesis. Nat. Immunol. 2006, 7, 344-353.
46. Hu, J.; Van den Steen, P.; Sang, Q.; Opdenakker, G. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat. Rev. Drug Discov. 2007, 6, 480-498.
47. Jimi, E.; Ghosh, S. Role of nuclear factor-kB in the immune system and bone. Immunol. Rev. 2005, 208, 80-87.
48. Epstein, F.; Barnes, P.; Karin, M. Nuclear factor-kB--a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 1997, 336, 1066-1071.
49. Albert, S.; Baldwin, J. Perspective series-NF-kB in defense and disease-The transcription factor NF-kB and human disease. J. Clin. Investig. 2001, 107, 3-6.
50. Macarthur, M.; Hold, G.; El-Omar, E. Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am. J. Physiol.-Gastrointest. Liver Physiol. 2004, 286, 515-520.
51. Da Silva, C.; Chalouni, C.; Williams, A.; Hartl, D.; Lee, C.; Elias, J. Chitin is a size-dependent regulator of macrophage TNF and IL-10 production. J. Immunol. 2009, 182, 3573-3582.
52. Kim, M.; You, H.; You, M.; Kim, N.; Shim, B.; Kim, H. Inhibitory Effect of water soluble chitosan on TNF α and IL 8 secretion from HMC 1. Cells 2004, 26, 401-409
53. Moon, J.; Kim, H.; Koo, H.; Joo, Y.; Nam, H.; Park, Y.; Kang, M. The antibacterial and immunostimulative effect of chitosan-oligosaccharides against infection by Staphylococcus aureus isolated from bovine mastitis. Appl. Microbiol. Biotechnol. 2007, 75, 989-998.
54. Yoon, H.; Moon, M.; Park, H.; Im, S.; Kim, Y. Chitosan oligosaccharide (COS) inhibits LPS-induced inflammatory effects in RAW 264.7 macrophage cells. Biochem. Biophys. Res. Commun. 2007, 358, 954-959.
55. Ueno, H.; Mori, T.; Fujinaga, T. Topical formulations and wound healing applications of chitosan. Adv. Drug Deliv. Rev. 2001, 52, 105-115.
56. Kim, M.; Kim, S. Chitooligosaccharides inhibit activation and expression of matrix metalloproteinase-2 in human dermal fibroblasts. FEBS Lett. 2006, 580, 2661-2666.
57. Gorzelanny, C.; Poppelmann, B.; Strozyk, E.; Moerschbacher, B.; Schneider, S. Specific interaction between chitosan and matrix metalloprotease 2 decreases the invasive activity of human melanoma cells. Biomacromolecules 2007, 8, 3035-3040.
58. Devlieghere, F.; Vermeulen, A.; Debevere, J. Chitosan: Antimicrobial activity, interactions with food components and applicability as a coating on fruit and vegetables. Food Microbiol. 2004, 21, 703-714.
59. Qin, C.; Xiao, Q.; Li, H.; Fang, M.; Liu, Y.; Chen, X.; Li, Q. Calorimetric studies of the action of chitosan-N-2-hydroxypropyl trimethyl ammonium chloride on the growth of microorganisms. Int. J. Biol. Macromol. 2004, 34, 121-126.
60. Chung, Y.; Su, Y.; Chen, C.; Jia, G.; Wang, H.; Wu, J.; Lin, J. Relationship between antibacterial activity of chitosan and surface characteristics of cell wall. Acta Pharmacol. Sinica 2004, 25, 932-936.
61. Helander, I.; Nurmiaho-Lassila, E.; Ahvenainen, R.; Rhoades, J.; Roller, S. Chitosan disrupts the barrier properties of the outer membrane of Gram-negative bacteria. Int. J. Food Microbiol. 2001, 71, 235-244.
62. Je, J.; Kim, S. Chitosan derivatives killed bacteria by disrupting the outer and inner membrane. J. Agric. Food Chem. 2006, 54, 6629-6633.
63. Liu, H.; Du, Y.; Wang, X.; Sun, L. Chitosan kills bacteria through cell membrane damage. Int. J. Food Microbiol. 2004, 95, 147-155.
64. Wang, X.; Du, Y.; Liu, H. Preparation, characterization and antimicrobial activity of chitosan-Zn complex. Carbohydr. Polym. 2004, 56, 21-26.
65. Chen, C.; Liau, W.; Tsai, G. Antibacterial effects of N-sulfonated and N-sulfobenzoyl chitosan and application to oyster preservation. J. Food Protect. 1998, 61, 1124-1128.
66. Tsai, G.; Su, W.; Chen, H.; Pan, C. Antimicrobial activity of shrimp chitin and chitosan from different treatments and applications of fish preservation. Fisher. Sci. 2002, 68, 170-177.
67. Jeon, Y.; Park, P.; Kim, S. Antimicrobial effect of chitooligosaccharides produced by bioreactor. Carbohydr. Polym. 2001, 44, 71-76.
68. Ilyina, A.; Tikhonov, V.; Albulov, A.; Varlamov, V. Enzymic preparation of acid-free-water-soluble chitosan. J. Dentistry 2000, 35, 563-568.
69. Jia, Z. Synthesis and antibacterial activities of quaternary ammonium salt of chitosan. Carbohydr. Res. 2001, 333, 1-6.
70. Suzuki, K.; Mikami, T.; Okawa, Y.; Tokoro, A.; Suzuki, S.; Suzuki, M. Antitumor effect of hexa- N-acetylchitohexaose and chitohexaose. Carbohydr. Res. 1986, 151, 403-408.
71. Maeda, Y.; Kimura, Y. Antitumor effects of various low-molecular-weight chitosans are due to increased natural killer activity of intestinal intraepithelial lymphocytes in sarcoma 180-bearing mice. J. Nutr. 2004, 134, 945-950.
72. Kobayashi, M.; Watanabe, T.; Suzuki, S.; Suzuki, M. Effect of N-acetylchitohexaose against Candida albicans infection of tumor-bearing mice. Microbiol. Immunol. 1990, 34, 413-426.
73. Kimura, Y.; Okuda, H. Prevention by chitosan of myelotoxicity, gastrointestinal toxicity and immunocompetent organic toxicity induced by 5-fluorouracil without loss of antitumor activity in mice. Cancer Sci. 1999, 90, 765-774.
74. Zhou, X.; Liu, D.; Liu, H.; Yang, Q.; Yao, K.; Wang, X.; Wang, L.; Yang, X. Effect of low molecular weight chitosans on drug permeation through mouse skin: 1. Transdermal delivery of baicalin. J. Pharm. Sci. 2010, 99, 2991-2998.
75. Huang, R.; Mendis, E.; Rajapakse, N.; Kim, S. Strong electronic charge as an important factor for anticancer activity of chitooligosaccharides (COS). Life Sci. 2006, 78, 2399-2408.
76. Shen, K.; Chen, M.; Chan, H.; Jeng, J.; Wang, Y. Inhibitory effects of chitooligosaccharides on tumor growth and metastasis. Food Chem. Toxicol. 2009, 47, 1864-1871.
77. Quan, H.; Zhu, F.; Han, X.; Xu, Z.; Zhao, Y.; Miao, Z. Mechanism of anti-angiogenic activities of chitooligosaccharides may be through inhibiting heparanase activity. Med. Hypotheses 2009, 73, 205-206.
78. Karagozlu, M.; Kim, J.; Karadeniz, F.; Kong, C.; Kim, S. Antiproliferative effect of aminoderivatized chitooligosaccharides on AGS human gastric cancer cells. Process Biochem. 2010, 45, 1523-1528
79. Wu, H.; Yao, Z.; Bai, X.; Du, Y.; Ma, X. Chitooligosaccharides inhibit nitric oxide mediated migration of endothelial cells In vitro and tumor angiogenesis in vivo. Carbohydr. Polym. 2010, 82, 927-932.
80. Harish Prashanth, K.; Tharanathan, R. Depolymerized products of chitosan as potent inhibitors of tumor-induced angiogenesis. Biochim. Biophys. Acta Gen. Subjects 2005, 1722, 22-29.
81. Lee, J.; Kang Decker, N.; Chatterjee, S.; Yao, J.; Friedman, S.; Shah, V. Mechanisms of nitric oxide interplay with Rho GTPase family members in modulation of actin membrane dynamics in pericytes and fibroblasts. Am. J. Pathol. 2005, 166, 1861-1870.
82. Cooke, J. NO and angiogenesis. Atheroscler. Suppl. 2003, 4, 53-60.
83. Rinaudo, M. Chitin and chitosan: Properties and applications. Prog. Polym. Sci. 2006, 31, 603-632.
84. Di Martino, A.; Sittinger, M.; Risbud, M. Chitosan: A versatile biopolymer for orthopaedic tissue-engineering. Biomaterials 2005, 26, 5983-5990.
85. Janes, K.; Fresneau, M.; Marazuela, A.; Fabra, A.; Alonso, M. Chitosan nanoparticles as delivery systems for doxorubicin. J. Controll. Release 2001, 73, 255-267.
86. De Campos, A.; Sanchez, A.; Alonso, M. Chitosan nanoparticles: A new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int. J. Pharm. 2001, 224, 159-168.
87. Xu, Y.; Du, Y. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int. J. Pharm. 2003, 250, 215-226.
88. Li, N.; Zhuang, C.; Wang, M.; Sun, X.; Nie, S.; Pan, W. Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. Int. J. Pharm. 2009, 379, 131-138.
89. Qi, L.; Xu, Z. In vivo antitumor activity of chitosan nanoparticles. Bioorg. Med. Chem.Lett. 2006, 16, 4243-4245.
90. Qi, L.; Xu, Z.; Jiang, X.; Li, Y.; Wang, M. Cytotoxic activities of chitosan nanoparticles and copper-loaded nanoparticles. Bioorg. Med. Chem. Lett. 2005, 15, 1397-1399.
91. Moghimi, S.; Hunter, A.; Murray, J. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol. Rev. 2001, 53, 283-318.
92. Kreuter, J. Peroral administration of nanoparticles. Adv. Drug Deliv. Rev. 1991, 7, 71-86.
93. Chouly, C.; Pouliquen, D.; Lucet, I.; Jeune, J.; Jallet, P. Development of superparamagnetic nanoparticles for MRI: Effect of particle size, charge and surface nature on biodistribution. J. Microencapsul. 1996, 13, 245-255.
94. Qi, L.; Xu, Z.; Jiang, X.; Hu, C.; Zou, X. Preparation and antibacterial activity of chitosan nanoparticles. Carbohydr. Res. 2004, 339, 2693-2700.
95. Qi, L.; Xu, Z. Lead sorption from aqueous solutions on chitosan nanoparticles. Colloid. Surface Physicochem. Eng. Aspect. 2004, 251, 183-190.
96. Junping, W.; Takayama, K.; Nagai, T.; Maitani, Y. Pharmacokinetics and antitumor effects of vincristine carried by microemulsions composed of PEG-lipid, oleic acid, vitamin E and cholesterol. Int. J. Pharm. 2003, 251, 13-21.
97. Yuan, F.; Dellian, M.; Fukumura, D.; Leunig, M.; Berk, D.; Torchilin, V.; Jain, R. Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size. Cancer Res. 1995, 55, 3752-3756.
98. Williams, J.; Lansdown, R.; Sweitzer, R.; Romanowski, M.; LaBell, R.; Ramaswami, R.; Unger, E. Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitors. J. Controll. Release 2003, 91, 167-172.